Platelet-Rich Plasma: Advances and Controversies in Hair Restoration and Skin Rejuvenation

Author:

Kourosh Arianne Shadi12,Santiago Mangual Kathyana P.13,Farah Ronda S.45,Rao Medha6,Hordinsky Maria K.4,Arruda Suleima7,Sadick Neil478

Affiliation:

1. Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts;

2. Harvard Medical School, Boston, Massachusetts;

3. David Geffen School of Medicine at UCLA, Los Angeles, California;

4. Department of Dermatology, University of Minnesota, Minneapolis, Minnesota;

5. Veteran's Affairs Medical Center, Minneapolis, Minnesota;

6. Robert Wood Johnson Medical School, New Brunswick, New Jersey;

7. Sadick Dermatology, New York, New York;

8. Weill Cornell Medical College, New York, New York

Abstract

BACKGROUND Platelet-rich plasma (PRP) and its combined therapeutic modalities have catalyzed new possibilities in dermatology; however, limitations in evidence and lack of consensus remain among clinicians regarding optimal composition, protocol, technique, and application. OBJECTIVE To provide an update and analysis of the evidence for PRP in hair restoration and skin rejuvenation through review of recent available data, highlighting controversies and expert insights to guide future studies, and stimulate discourse and innovations benefitting patients. METHODS A structured review and expert analysis of PubMed publications before October 2023, with a focus on recent literature from January 2020 through October 2023. RESULTS AND CONCLUSION Growing literature supports the utility and benefits of PRP and related autologous products for applications for skin and hair, with strongest evidence for androgenetic alopecia and skin rejuvenation. However, this is limited by lack of consensus regarding best practices and protocols. Randomized, controlled trials with uniform metrics comparing outcomes of various compositions of autologous blood products, preparation methods, dosimetry, and frequency of treatments are still required. This will allow the medical discourse to grow beyond the realm of expert opinion into consensus, standardization, and more wide spread adoption of best practices that will benefit patients.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3